Authors:
Schorlemmer, HU
Kurrle, R
Schleyerbach, R
Bartlett, RR
Citation: Hu. Schorlemmer et al., In vivo lymphoproliferation in the popliteal lymph node (PLN) assay can beinhibited by leflunomide's active metabolite A77 1726, INFLAMM RES, 48, 1999, pp. S111-S112
Authors:
Schorlemmer, HU
Kurrle, R
Schleyerbach, R
Bartlett, RR
Citation: Hu. Schorlemmer et al., Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis, INFLAMM RES, 48, 1999, pp. S113-S114
Authors:
Schorlemmer, HU
Kurrle, R
Schleyerbach, R
Bartlett, RR
Citation: Hu. Schorlemmer et al., Generation of O-2(-) radicals in macrophages can be inhibited in vitro andin vivo by derivatives of leflunomide's primary metabolite, INFLAMM RES, 48, 1999, pp. S117-S118
Citation: J. Czech et al., The antiproliferative effect of malononitrilamides (MNAs) on vascular smooth muscle cells is antagonized by exogenous uridine, INFLAMM RES, 48, 1999, pp. S128-S129
Citation: Hu. Schorlemmer et al., Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model, TRANSPLAN P, 31(1-2), 1999, pp. 851-853
Authors:
Schorlemmer, HU
Bartlett, RR
Lindner, JK
Kurrle, R
Citation: Hu. Schorlemmer et al., Coadministration of malononitrilamides and tacrolimus induces tolerance ina rat skin allograft model, TRANSPLAN P, 31(1-2), 1999, pp. 1184-1188
Citation: J. Czech et al., Inhibition of smooth muscle cell proliferation by A77-1726 and its derivatives can be antagonized by uridine, INT J IMM T, 14(4), 1998, pp. 185-191
Authors:
Schorlemmer, HU
Kurrle, R
Schleyerbach, R
Citation: Hu. Schorlemmer et al., A77-1726, leflunomide's active metabolite, inhibits in vivo lymphoproliferation in the popliteal lymph node assay, INT J IMM T, 14(4), 1998, pp. 205-211
Authors:
Schorlemmer, HU
Kurrle, R
Schleyerbach, R
Citation: Hu. Schorlemmer et al., Leflunomide's active metabolite A77-1726 and its derivatives, the malononitrilamides, inhibit the generation of oxygen radicals in mononuclear phagocytes, INT J IMM T, 14(4), 1998, pp. 213-222
Authors:
Schorlemmer, HU
Bartlett, RR
Lindner, JK
Kurrle, R
Citation: Hu. Schorlemmer et al., Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus, TRANSPLAN P, 30(8), 1998, pp. 4099-4103
Citation: Hu. Schorlemmer et R. Kurrle, Combination therapy of malononitrilamides and tacrolimus (FK 506) induced long-term xenograft survival, TRANSPLAN P, 30(8), 1998, pp. 4170-4173
Authors:
Lang, D
Knop, J
Wesche, H
Raffetseder, U
Kurrle, R
Boraschi, D
Martin, MU
Citation: D. Lang et al., The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: A novel mechanism of regulation of IL-1 responsiveness, J IMMUNOL, 161(12), 1998, pp. 6871-6877